Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/201906
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBohner, Marc-
dc.contributor.authorMaazouz, Yassine-
dc.contributor.authorGinebra, Maria Pau-
dc.contributor.authorHabibovic, Pamela-
dc.contributor.authorSchoenecker, Jonathan G.-
dc.contributor.authorSeeherman, Howard-
dc.contributor.authorvan den Beucken, Jeroen J.J.P.-
dc.contributor.authorWitte, Frank-
dc.date.accessioned2023-09-13T10:43:56Z-
dc.date.available2023-09-13T10:43:56Z-
dc.date.issued2022-04-06-
dc.identifier.issn1878-7568-
dc.identifier.urihttp://hdl.handle.net/2445/201906-
dc.description.abstractHeterotopic ossification (HO) is a condition triggered by an injury leading to the formation of mature lamellar bone in extraskeletal soft tissues. Despite being a frequent complication of orthopedic and trauma surgery, brain and spinal injury, the etiology of HO is poorly understood. The aim of this study is to evaluate the hypothesis that a sustained local ionic homeostatic imbalance (SLIHI) created by mineral formation during tissue calcification modulates inflammation to trigger HO. This evaluation also considers the role SLIHI could play for the design of cell-free, drug-free osteoinductive bone graft substitutes. The evaluation contains five main sections. The first section defines relevant concepts in the context of HO and provides a summary of proposed causes of HO. The second section starts with a detailed analysis of the occurrence and involvement of calcification in HO. It is followed by an explanation of the causes of calcification and its consequences. This allows to speculate on the potential chemical modulators of inflammation and triggers of HO. The end of this second section is devoted to in vitro mineralization tests used to predict the ectopic potential of materials. The third section reviews the biological cascade of events occurring during pathological and material-induced HO, and attempts to propose a quantitative timeline of HO formation. The fourth section looks at potential ways to control HO formation, either acting on SLIHI or on inflammation. Chemical, physical, and drug-based approaches are considered. Finally, the evaluation finishes with a critical assessment of the definition of osteoinduction.-
dc.format.extent24 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier BV-
dc.relation.isformatofhttps://doi.org/10.1016/j.actbio.2022.03.057-
dc.relation.ispartofActa Biomaterialia, 2022, vol. 145, p. 1-24-
dc.relation.urihttps://doi.org/10.1016/j.actbio.2022.03.057-
dc.rightscc by (c) Bohner, Marc et al., 2022-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))-
dc.subject.classificationCalcificació-
dc.subject.classificationOssificació-
dc.subject.classificationHomeòstasi-
dc.subject.otherCalcification-
dc.subject.otherOssification-
dc.subject.otherHomeostasis-
dc.titleSustained local ionic homeostatic imbalance caused by calcification modulates inflammation to trigger heterotopic ossification-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2023-09-06T07:13:27Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina6548039-
dc.identifier.pmid35398267-
Appears in Collections:Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))

Files in This Item:
File Description SizeFormat 
2022_ActBio_Sustained_GinebraMP.pdf3.11 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons